Article

Computer-based evolutionary search for a nonlinear conversion function for establishing in vitro-in vivo correlation (IVIVC) of oral drug formulations.

Graduate School of Pharmaceutical Sciences, Kyoto University, Japan.
Drug Metabolism and Pharmacokinetics (impact factor: 2.32). 12/2011; 27(3):280-5. pp.280-5
Source: PubMed

ABSTRACT Establishment of in vitro-in vivo correlation (IVIVC) accelerates optimization of desirable drug formulations and/or modification of the manufacturing processes in the scale-up and post-approval periods. This article presents a method of finding the optimal conversion function for establishing Level A point-to-point IVIVC, based on a computer-based evolutionary search technique. Gene expression programming (GEP) is a technique for optimizing a mathematical expression tree with the help of a genetic algorithm. A parameter optimization routine, which minimizes the number of parameters in the mathematical expression trees and estimates the best-fit parameter values, was implemented in the GEP algorithm. Feasibility of the computer program was investigated using the in vitro and in vivo data for sustained release diltiazem formulations. It provided a mathematical equation that, from their in vitro dissolution profiles, successfully predicts the plasma concentration profiles of three different formulations of diltiazem following oral administration. Because the present approach does not use intravenous injection data like conventional IVIVC analyses, it is widely applicable to the evaluation of various oral formulations.

0 0
 · 
0 Bookmarks
 · 
43 Views

Keywords

best-fit parameter values
 
computer-based evolutionary search technique
 
conventional IVIVC analyses
 
desirable drug formulations
 
different formulations
 
estimates
 
Feasibility
 
genetic algorithm
 
GEP algorithm
 
manufacturing processes
 
mathematical equation
 
optimal conversion function
 
oral administration
 
parameter optimization routine
 
plasma concentration profiles
 
point-to-point IVIVC
 
post-approval periods
 
release diltiazem formulations
 
various oral formulations
 
vivo data
 

Fumiyoshi Yamashita